On April 12, 2016, ACC members representing the Health Law Committee held meetings with leaders in the Department of Health and Human Services Office for Civil Rights and Office of the Inspector General, Office of the Inspector General, and the … Continue reading
The ACC “Meet the Regulator” series provides members with the exclusive opportunity to sit down with agency personnel to discuss issues of mutual importance. The Chatham House Rule forum allows both sides to analyze the practical implications of regulatory rules … Continue reading
One of the terrific benefits of ACC membership is direct access to decision makers – those who craft the policies and rules in which our members must become experts. On June 6, 2013, ACC Advocacy and the Employment and Labor … Continue reading
ACC and its FInancial Services Committee are pleased to announce an ACC-members only regulator meeting with the Consumer Financial Protection Bureau (CFPB). Borne from the 2010 Dodd-Frank law, the CFPB is charged with implementing and enforcing consumer financial law. With almost … Continue reading
Guest blogger: Lily Hughes is VP & Associate General Counsel of Ingram Micro Inc., a Fortune 100 global leader in IT distribution, mobile device lifecycle services and logistics solutions. Lily advises the company’s senior executives and business teams on corporate securities and regulatory requirements, corporate governance, finance & treasury matters, investor relations and communications, tax, executive compensation, mergers & acquisitions, equity plans, and strategic vendor and customer agreements.
Even without a permanent director, the Securities and Exchange Commission’s Division of Corporate Finance is clear on its priorities and the work it plans to finish. On Friday, May 10, 2013, ACC Advocacy and the Corporate and Securities Law Committee hosted our annual ACC-members only meeting with the Division. Continue reading
On January 29, 2013, ACC Advocacy staff attended the USPTO’s BioTech/Medical Device Technology Customer Partnership Forum. The forum was designed to promote discussion between practitioners and the USPTO on current practices and challenges facing all parties in the biotech and … Continue reading